A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
for Alzheimer Disease
Drug: KarXT
48 locations incl. Chandler
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 55 - 90
Code: NCT06937229·Phase 3·Recruiting